{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:39:40Z","timestamp":1789886380727,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ahj.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T13:45:52Z","timestamp":1499521552000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9864-1417","authenticated-orcid":false,"given":"Oluwaseun E.","family":"Fashanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye L.","family":"Norby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed Z.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-8323","authenticated-orcid":false,"given":"Alvaro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Folsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.07.001_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.disamonth.2012.12.002","article-title":"Atrial fibrillation","volume":"59","author":"Wadke","year":"2013","journal-title":"Dis Mon"},{"key":"10.1016\/j.ahj.2017.07.001_bb0010","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2017.07.001_bb0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.07.001_bb0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2017.07.001_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/HCO.0000000000000027","article-title":"Mechanisms of persistent atrial fibrillation","volume":"29","author":"Jalife","year":"2014","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ahj.2017.07.001_bb0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"de Boer","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2017.07.001_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2009","article-title":"Pathophysiological mechanisms of atrial fibrillation: a translational appraisal","volume":"91","author":"Schotten","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ahj.2017.07.001_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacbts.2016.03.003","article-title":"Galectin-3 regulates atrial fibrillation remodeling and predicts catheter ablation outcomes","volume":"1","author":"Takemoto","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ahj.2017.07.001_bb0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.12659\/MSM.890635","article-title":"Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation","volume":"20","author":"Sonmez","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ahj.2017.07.001_bb0050","doi-asserted-by":"crossref","first-page":"e0123574","DOI":"10.1371\/journal.pone.0123574","article-title":"Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation","volume":"10","author":"Kornej","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2017.07.001_bb0055","doi-asserted-by":"crossref","first-page":"34357","DOI":"10.1038\/srep34357","article-title":"Serum galectin-3 levels predict recurrences after ablation of atrial fibrillation","volume":"6","author":"Clementy","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ahj.2017.07.001_bb0060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/heartjnl-2015-308975","article-title":"Serial galectin-3 and future cardiovascular disease in the general population","volume":"102","author":"van der Velde","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2017.07.001_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinbiochem.2010.02.001","article-title":"Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure","volume":"43","author":"Christenson","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ahj.2017.07.001_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ejhf.21","article-title":"Plasma galectin 3 and heart failure risk in the Physicians' Health Study","volume":"16","author":"Djousse","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2017.07.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","author":"Ho","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.07.001_bb0080","doi-asserted-by":"crossref","first-page":"e47385","DOI":"10.1371\/journal.pone.0047385","article-title":"A genome-wide association study of circulating galectin-3","volume":"7","author":"de Boer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2017.07.001_bb0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: design and objectives","volume":"129","author":"ARIC Investigators","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2017.07.001_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2009.05.010","article-title":"Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study","volume":"158","author":"Alonso","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.07.001_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCULATIONAHA.115.020090","article-title":"Trajectories of cardiovascular risk factors and incidence of atrial fibrillation over a 25-year follow-up: the ARIC study (Atherosclerosis Risk in Communities)","volume":"134","author":"Norby","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.07.001_bb0100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/aje\/kwt086","article-title":"Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study","volume":"178","author":"Whelton","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2017.07.001_bb0105","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/ndt\/gfq179","article-title":"Chronic kidney disease and venous thromboembolism: a prospective study","volume":"25","author":"Folsom","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2017.07.001_bb0110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","article-title":"Troponin T, NT-pro BNP, and incidence of stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"44","author":"Folsom","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2017.07.001_bb0115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0895-4356(03)00055-6","article-title":"Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study","volume":"56","author":"Chambless","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ahj.2017.07.001_bb0120","doi-asserted-by":"crossref","first-page":"e68095","DOI":"10.1371\/journal.pone.0068095","article-title":"Best practices and joint calling of the Human Exome BeadChip: the CHARGE Consortium","volume":"8","author":"Grove","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2017.07.001_bb0125","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.clinbiochem.2015.04.021","article-title":"Galectin-3 in atrial fibrillation: simple bystander, player or both?","volume":"48","author":"Lippi","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ahj.2017.07.001_bb0130","doi-asserted-by":"crossref","first-page":"e002347","DOI":"10.1161\/JAHA.115.002347","article-title":"Circulating galectin-3 is associated with cardiometabolic disease in the community","volume":"5","author":"Nayor","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2017.07.001_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2016.08.172","article-title":"New onset atrial fibrillation is associated with elevated galectin-3 levels","volume":"223","author":"Chen","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2017.07.001_bb0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5603\/CJ.2013.0157","article-title":"The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty","volume":"20","author":"Szadkowska","year":"2013","journal-title":"Cardiol J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317301990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317301990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:15Z","timestamp":1757570295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317301990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":28,"alternative-id":["S0002870317301990"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.07.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}